Identify Risk Factors for Sudden Death in Epilepsy
This study looked at sudden unexpected death in epilepsy (SUDEP), which is a major cause of death related to epilepsy.
This hub covers pediatric epilepsy in infants, kids, and teens, including diagnosis, syndromes, development, school plans, and safety. New studies translated into clear takeaways for parents.
Usually when two appropriate medications haven’t controlled seizures.
Many families benefit and it depends on seizure frequency, medications, and learning needs.
Often yes, with smart precautions. Ask your neurologist or epileptologist about your child’s specific risks.
Clusters, prolonged seizures, breathing trouble, new weakness, or major regression.
This study looked at sudden unexpected death in epilepsy (SUDEP), which is a major cause of death related to epilepsy.
Researchers studied children with drug-resistant epilepsy (DRE) to find better ways to predict the success of epilepsy surgery.
Researchers studied the effectiveness and safety of two medications, levetiracetam (LEV) and phenobarbital (PB), for treating seizures in newborns.
Researchers studied the use of magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) as a treatment for children with drug-resistant epilepsy, which means their seizures do not respond to standard medications.
Researchers studied 231 children who experienced febrile seizures, which are seizures triggered by fever, to see if they could predict who might develop epilepsy or a specific type of epilepsy called genetic epilepsy with febrile seizures plus (GEFS+).
Researchers studied how much of a brain tumor called glioma should be removed during surgery.
This study looked at how pediatric epilepsy centers in the United States make decisions about surgery for children with Lennox-Gastaut Syndrome (LGS), a severe type of epilepsy.
Researchers studied CLN2 disease, a rare and serious condition that affects the brain and nervous system, particularly in children.
This study looked at how effective and safe cannabidiol (CBD) is for children with drug-resistant epilepsy.